Morin post-treatment surpassed calpeptin in ameliorating 3-NP-induced cortical neurotoxicity via modulation of glutamate/calpain axis, Kidins220, and BDNF/TrkB/AKT/CREB trajectory

Int Immunopharmacol. 2023 Mar:116:109771. doi: 10.1016/j.intimp.2023.109771. Epub 2023 Feb 1.

Abstract

The neuroprotective capacity of morin hydrate (MH), a potent antioxidant flavonoid, and calpeptin (CP), a calpain inhibitor, was documented against different insults but not Huntington's disease (HD). Accordingly, we aim to assess the neuroprotective potential of MH and/or CP in a 3-nitropropionic acid (3-NP)-induced HD model. The 3-NP-treated rats were post-treated with saline, MH, CP, or MH + CP for a week. Post-treatment with MH and/or CP amended motor function (beam walking test) and short-/ long-term spatial memory (novel object recognition test) and improved cortical microscopic architecture. On the molecular level, MH, and to a lesser extent CP, inhibited the cortical content/expression of glutamate, calpain, and Kidins220 and abated the inflammatory molecules, nuclear factor (NF)-κB, tumor necrosis factor-α, and interleukin-1β, as well as lipid peroxidation. However, MH, but barely CP, activated the molecules of the neuroprotective trajectory; viz., brain-derived neurotrophic factor (BDNF), tropomyosin-related kinase receptor B (TrkB), protein kinase B (AKT), and cAMP response element-binding protein (CREB). Compared to the single treatments, the combination regimen mediated further reductions in the cortical contents of glutamate, calpain, and Kidins220, effects that extended to entail the anti-inflammatory/anti-oxidant potentials of MH and to a greater extent CP. However, the combination of MH strengthened the fair effect of CP on the survival signaling pathway BDNF/TrkB/AKT/CREB. In conclusion, MH, CP, and especially their combination, afforded neuroprotection against HD through curbing the glutamate/calpain axis, Kidins220, as well as NF-κB-mediated neuroinflammation/oxidative stress, besides activating the BDNF/TrkB/AKT/CREB hub that was partly dependent on calpain inhibition.

Keywords: BDNF; Calpain; Glutamate; Kidins220; Neuro-inflammation; Oxidative stress.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Antioxidants / therapeutic use
  • Brain-Derived Neurotrophic Factor / metabolism
  • Calpain
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Flavonoids
  • Glutamic Acid
  • Membrane Proteins
  • Neuroprotective Agents* / pharmacology
  • Neuroprotective Agents* / therapeutic use
  • Phosphoproteins
  • Proto-Oncogene Proteins c-akt* / metabolism
  • Rats

Substances

  • Antioxidants
  • Brain-Derived Neurotrophic Factor
  • Calpain
  • calpeptin
  • Cyclic AMP Response Element-Binding Protein
  • Flavonoids
  • Glutamic Acid
  • Kidins220 protein, rat
  • Membrane Proteins
  • morin
  • Neuroprotective Agents
  • Phosphoproteins
  • Proto-Oncogene Proteins c-akt
  • Bdnf protein, rat
  • Ntrk2 protein, rat